Literature DB >> 17260104

Reduced pulmonary function is associated with lower levels of endogenous total and free testosterone. The Tromsø study.

Johan Svartberg1, Henrik Schirmer, Astri Medbø, Hasse Melbye, Ulf Aasebø.   

Abstract

Men with chronic obstructive pulmonary disease have reduced endogenous testosterone levels. Little is known, however, about the relationship between pulmonary function and endogenous testosterone levels in a general population. In the present study we have examined the cross-sectional associations between sex hormones measured by immunoassay and pulmonary function assessed with spirometry and oxygen saturation in 2,197 men participating in the fifth Tromsø study. The data were analyzed by univariate correlations, multiple linear regression analyses and analyses of variance and covariance. Total and free testosterone were positively and independently associated with forced vitality capacity, FVC (% of predicted) (P = 0.001 and P = 0.006, respectively) and forced expiratory volume in 1 second, FEV(1 )(% predicted) (P = 0.033 and P = 0.002, respectively), and men with severe pulmonary obstruction (FEV(1) % of predicted < 50) had lower free testosterone levels (P = 0.005). In this cross-sectional data from Tromsø, a reduction in pulmonary function was associated with lower levels of total and free testosterone. We suggest that the reduction of total and free testosterone could be due to an alteration of the hypothalamic-pituitary response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17260104     DOI: 10.1007/s10654-006-9095-9

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  18 in total

1.  Cigarette smoking and increased endogenous estrogen levels in men.

Authors:  E Barrett-Connor; K T Khaw
Journal:  Am J Epidemiol       Date:  1987-08       Impact factor: 4.897

Review 2.  Rationale for anabolic therapy to facilitate rehabilitation in chronic obstructive pulmonary disease.

Authors:  R Casaburi
Journal:  Baillieres Clin Endocrinol Metab       Date:  1998-10

3.  Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy.

Authors:  A Kamischke; D E Kemper; M A Castel; M Lüthke; C Rolf; H M Behre; H Magnussen; E Nieschlag
Journal:  Eur Respir J       Date:  1998-01       Impact factor: 16.671

4.  Evaluation of assays available to measure free testosterone.

Authors:  John E Morley; Ping Patrick; H M Perry
Journal:  Metabolism       Date:  2002-05       Impact factor: 8.694

5.  Testosterone treatment improves body composition and sexual function in men with COPD, in a 6-month randomized controlled trial.

Authors:  J Svartberg; U Aasebø; A Hjalmarsen; J Sundsfjord; R Jorde
Journal:  Respir Med       Date:  2004-09       Impact factor: 3.415

6.  Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial.

Authors:  A M Schols; P B Soeters; R Mostert; R J Pluymers; E F Wouters
Journal:  Am J Respir Crit Care Med       Date:  1995-10       Impact factor: 21.405

7.  Reversal of sexual impotence in male patients with chronic obstructive pulmonary disease and hypoxemia with long-term oxygen therapy.

Authors:  U Aasebø; A Gyltnes; R M Bremnes; A Aakvaag; L Slørdal
Journal:  J Steroid Biochem Mol Biol       Date:  1993-12       Impact factor: 4.292

8.  The associations of age, lifestyle factors and chronic disease with testosterone in men: the Tromsø Study.

Authors:  Johan Svartberg; Monica Midtby; Kaare H Bønaa; Johan Sundsfjord; Ragnar M Joakimsen; Rolf Jorde
Journal:  Eur J Endocrinol       Date:  2003-08       Impact factor: 6.664

9.  Serum testosterone depression associated with hypoxia in respiratory failure.

Authors:  P D Semple; G H Beastall; W S Watson; R Hume
Journal:  Clin Sci (Lond)       Date:  1980-01       Impact factor: 6.124

10.  The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients.

Authors:  I M Ferreira; I T Verreschi; L E Nery; R S Goldstein; N Zamel; D Brooks; J R Jardim
Journal:  Chest       Date:  1998-07       Impact factor: 9.410

View more
  24 in total

Review 1.  Aging and sex hormones in males.

Authors:  Maria Chiara Decaroli; Vincenzo Rochira
Journal:  Virulence       Date:  2016-11-10       Impact factor: 5.882

Review 2.  Hormonal Effects on Asthma, Rhinitis, and Eczema.

Authors:  Natalia Weare-Regales; Sergio E Chiarella; Juan Carlos Cardet; Y S Prakash; Richard F Lockey
Journal:  J Allergy Clin Immunol Pract       Date:  2022-04-15

Review 3.  Female Sex and Gender in Lung/Sleep Health and Disease. Increased Understanding of Basic Biological, Pathophysiological, and Behavioral Mechanisms Leading to Better Health for Female Patients with Lung Disease.

Authors:  MeiLan K Han; Emilio Arteaga-Solis; John Blenis; Ghada Bourjeily; Deborah J Clegg; Dawn DeMeo; Jeanne Duffy; Ben Gaston; Nicola M Heller; Anna Hemnes; Elizabeth Petri Henske; Raksha Jain; Tim Lahm; Lisa H Lancaster; Joyce Lee; Marianne J Legato; Sherry McKee; Reena Mehra; Alison Morris; Y S Prakash; Martin R Stampfli; Rashmi Gopal-Srivastava; Aaron D Laposky; Antonello Punturieri; Lora Reineck; Xenia Tigno; Janine Clayton
Journal:  Am J Respir Crit Care Med       Date:  2018-10-01       Impact factor: 21.405

4.  Association of Circulating Sex Hormones With Inflammation and Disease Severity in Patients With COVID-19.

Authors:  Sandeep Dhindsa; Nan Zhang; Michael J McPhaul; Zengru Wu; Amit K Ghoshal; Emma C Erlich; Kartik Mani; Gwendalyn J Randolph; John R Edwards; Philip A Mudd; Abhinav Diwan
Journal:  JAMA Netw Open       Date:  2021-05-03

5.  The Rotterdam Study: 2012 objectives and design update.

Authors:  Albert Hofman; Cornelia M van Duijn; Oscar H Franco; M Arfan Ikram; Harry L A Janssen; Caroline C W Klaver; Ernst J Kuipers; Tamar E C Nijsten; Bruno H Ch Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Jacqueline C M Witteman
Journal:  Eur J Epidemiol       Date:  2011-08-30       Impact factor: 8.082

6.  Testosterone-to-estradiol ratio and lung function in a prospective study of Puerto Rican youth.

Authors:  Yueh-Ying Han; Erick Forno; Selma F Witchel; Michelle L Manni; Edna Acosta-Pérez; Glorisa Canino; Juan C Celedón
Journal:  Ann Allergy Asthma Immunol       Date:  2021-04-20       Impact factor: 6.248

7.  The Rotterdam Study: 2010 objectives and design update.

Authors:  Albert Hofman; Monique M B Breteler; Cornelia M van Duijn; Harry L A Janssen; Gabriel P Krestin; Ernst J Kuipers; Bruno H Ch Stricker; Henning Tiemeier; André G Uitterlinden; Johannes R Vingerling; Jacqueline C M Witteman
Journal:  Eur J Epidemiol       Date:  2009       Impact factor: 8.082

Review 8.  Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony.

Authors:  Aibek E Mirrakhimov
Journal:  Cardiovasc Diabetol       Date:  2012-10-27       Impact factor: 9.951

Review 9.  Sex, Cells, and Asthma.

Authors:  Sergio E Chiarella; Juan Carlos Cardet; Y S Prakash
Journal:  Mayo Clin Proc       Date:  2021-07       Impact factor: 11.104

10.  Endogenous testosterone level and testosterone supplementation therapy in chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis.

Authors:  Evan Atlantis; Paul Fahey; Belinda Cochrane; Gary Wittert; Sheree Smith
Journal:  BMJ Open       Date:  2013-08-13       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.